Cargando…
Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity
Among inborn errors of immunity (IEIs), some conditions are characterized by inflammation and autoimmunity at the front line and are particularly challenging to treat. Monogenic diseases associated with gain-of-function mutations in genes critical for cytokine signaling through the JAK-STAT pathway...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484879/ https://www.ncbi.nlm.nih.gov/pubmed/34603291 http://dx.doi.org/10.3389/fimmu.2021.717388 |